Atlas Trials

Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer

Clinical trial NCT05645094 · UNKNOWN

Trial details

NCT number
NCT05645094
Sponsor
Fudan University
Status
UNKNOWN
Study type
OBSERVATIONAL
Locally Advanced Rectal CarcinomaMSI-High
Start date
2023-01-01
Primary completion
2023-06-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.